Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvy Laporte

Showing results (71-80 of 132) with videos related to

Pageof 14
Sort By:
Therapie|May 17, 2021
Claire Guy, Marie-Noelle Beyens, Xavier Delavenne, et al.
Plos One|July 14, 2017
Correction: Tissue factor pathway inhibitor for prediction of placenta-mediated adverse pregnancy outcomes in high-risk women: AngioPred studyAurélie Di Bartolomeo, Céline Chauleur, Brigitte Tardy, et al.
Journal of the American College of Cardiology|March 1, 2014
Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding riskAlfonso Muriel, David Jiménez, Drahomir Aujesky, et al.
Scientific Reports|July 20, 2021
Meta-regression of randomized control trials with antithrombotics: weak correlation between net clinical benefit and all cause-mortalityRoubi Kilo, Silvy Laporte, Rama Arab, et al.
Journal of Clinical Epidemiology|April 17, 2020
Early detection of the existence or absence of the treatment effect: A cumulative meta-analysisSilvy Laporte, Céline Chapelle, Jane-Chloé Trone, et al.
Haematologica|January 29, 2003
Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trialPatrick Mismetti, Dominique Mille, Silvy Laporte, et al.
Pharmacological Research|June 29, 2016
Direct oral anticoagulants: Current indications and unmet needs in the treatment of venous thromboembolismLaurent Bertoletti, Edouard Ollier, Cécile Duvillard, et al.
Archives of Cardiovascular Diseases|December 13, 2023
Anticoagulant treatment of cancer-associated thromboembolismIsabelle Mahé, Didier Mayeur, Francis Couturaud, et al.
Thrombosis and Haemostasis|January 26, 2012
Prevalence of poor biological response to clopidogrel: a systematic reviewNora Mallouk, Carine Labruyère, Jean-Luc Reny, et al.
Thrombosis and Haemostasis|August 14, 2018
Benefit of Risk Score-Guided Prophylaxis in Pregnant Women at Risk of Thrombotic Events: A Controlled Before-and-After Implementation StudyCéline Chauleur, Jean-Christophe Gris, Silvy Laporte, et al.
Pageof 14

Showing results (71-80 of 132) with videos related to

Sort By:
Pageof 14
Therapie|May 17, 2021
Claire Guy, Marie-Noelle Beyens, Xavier Delavenne, et al.
Plos One|July 14, 2017
Correction: Tissue factor pathway inhibitor for prediction of placenta-mediated adverse pregnancy outcomes in high-risk women: AngioPred studyAurélie Di Bartolomeo, Céline Chauleur, Brigitte Tardy, et al.
Journal of the American College of Cardiology|March 1, 2014
Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding riskAlfonso Muriel, David Jiménez, Drahomir Aujesky, et al.
Scientific Reports|July 20, 2021
Meta-regression of randomized control trials with antithrombotics: weak correlation between net clinical benefit and all cause-mortalityRoubi Kilo, Silvy Laporte, Rama Arab, et al.
Journal of Clinical Epidemiology|April 17, 2020
Early detection of the existence or absence of the treatment effect: A cumulative meta-analysisSilvy Laporte, Céline Chapelle, Jane-Chloé Trone, et al.
Haematologica|January 29, 2003
Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trialPatrick Mismetti, Dominique Mille, Silvy Laporte, et al.
Pharmacological Research|June 29, 2016
Direct oral anticoagulants: Current indications and unmet needs in the treatment of venous thromboembolismLaurent Bertoletti, Edouard Ollier, Cécile Duvillard, et al.
Archives of Cardiovascular Diseases|December 13, 2023
Anticoagulant treatment of cancer-associated thromboembolismIsabelle Mahé, Didier Mayeur, Francis Couturaud, et al.
Thrombosis and Haemostasis|January 26, 2012
Prevalence of poor biological response to clopidogrel: a systematic reviewNora Mallouk, Carine Labruyère, Jean-Luc Reny, et al.
Thrombosis and Haemostasis|August 14, 2018
Benefit of Risk Score-Guided Prophylaxis in Pregnant Women at Risk of Thrombotic Events: A Controlled Before-and-After Implementation StudyCéline Chauleur, Jean-Christophe Gris, Silvy Laporte, et al.
Pageof 14